Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Posts 33 Percent Rise in Q2 Revenues, Notes Strong Interest in New Mass Spec Systems

Premium

Bruker this week reported a 33 percent increase year over year in Q2 revenues with its Scientific Instruments division, which houses its mass spectrometry business, also growing 33 percent.

While CEO Frank Laukien noted during a call discussing the results that recent mass spec releases like the maXis 4G UHR-QTOF and the maXis Impact likely hadn't contributed to these revenues, he said "order uptake is strong" for the new instruments, and they are "getting very good traction, very good interest."

For the three months ended June 30, the company posted $401.2 million in revenues, up from $300.9 million a year ago, surpassing analysts' forecasts of $384.1 million. Its Scientific Instruments division totaled $377.9 million in revenues, compared to $284.9 million a year ago.

Like other mass spec vendors (PM 07/29/2011), Bruker saw some weakness in the academic and government-funded markets, a trend Laukien said the company expects to continue – particularly in the US – in the second half of the year.

Academic funding in Europe and Asia, however, "has been quite good," he noted.

Bruker's profit for the quarter slid 2 percent to $22.1 million, or $.13 per share, from $22.6 million, or $.14 a share, a year ago. On an adjusted basis, EPS was $.20, just short of the consensus Wall Street estimate of $.21.

The firm's R&D expenses increased to $44.3 million from $31.2 million, a 42 percent uptick. Its SG&A costs rose 52 percent to $97.5 million from $64 million a year ago.

Bruker ended the quarter with $173.1 million in cash, cash equivalents, and restricted cash.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.